Pacira reported $5.01M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Astellas Pharma 4.12B 2.94B Mar/2024
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
J&J 332M 51M Mar/2025
Ligand Pharmaceuticals USD 1.77M 160K Mar/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 156M 13M Jun/2025
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025
Xeris Pharmaceuticals USD 948K 38K Jun/2025
Zoetis 19M 4M Jun/2025